Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
PaperCitations, authors & open-access status
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 196 citations, 2022 year and bronze oa status.
196
Citations
2022
Year
bronze
OA Status